Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results

EXXUA - with only a partial quarter of full sales force support - contributed $2.4 million in net revenue supported by rapid monthly compounding script growth ratesTotal net revenue of $12.4 millionAdjusted EBITDA1 of $(2.8) million, which includes …